OCTAGON CAPITAL PARTNERS
Octagon Capital Corporation is an independent Canadian investment dealer providing opportunities and advice to institutional investors and corporate clients. Octagon is strategically comprised of intelligent, motivated, successful individuals from diverse, complimentary backgrounds, who work together as a capital markets team to provide the highest level of service to their clients.
OCTAGON CAPITAL PARTNERS
Industry:
Financial Services
Founded:
1993-01-01
Status:
Active
Contact:
417-889-0044
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins Sitelinks Search Box Yoast WordPress SEO Plugin
Similar Organizations
Maryland Momentum Fund
Maryland Momentum Fund is an investment Fund
Paradigm Capital
A research-driven investment dealer
Belay
SImple, affordable peace of mind for your investments.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-08-19 | Abogen Biosciences | Octagon Capital Partners investment in Series C - Abogen Biosciences | 1000 M USD |
| 2021-08-04 | Sonoma BioTherapeutics | Octagon Capital Partners investment in Series B - Sonoma BioTherapeutics | 265 M USD |
| 2021-07-21 | Undercover Snacks | Octagon Capital Partners investment in Venture Round - Undercover Snacks | 13.7 M USD |
| 2021-06-22 | Biocytogen | Octagon Capital Partners investment in Series E - Biocytogen | N/A |
| 2021-03-24 | Bioheng | Octagon Capital Partners investment in Series B - Bioheng | 520 M CNY |
| 2021-03-03 | Century Therapeutics | Octagon Capital Partners investment in Series C - Century Therapeutics | 160 M USD |
| 2021-02-25 | Cullgen | Octagon Capital Partners investment in Series B - Cullgen | 50 M USD |
| 2021-01-19 | Vera Therapeutics | Octagon Capital Partners investment in Series C - Vera Therapeutics | 80 M USD |
| 2020-12-31 | Immvira | Octagon Capital Partners investment in Series C - Immvira | N/A |
| 2020-09-30 | Sonoma BioTherapeutics | Octagon Capital Partners investment in Series A - Sonoma BioTherapeutics | 30 M USD |